Redefining Where Cannabinoid Therapy Belongs
Kazmira is a prescription-first cannabinoid therapy platform, built for the healthcare system—not the wellness aisle. Operating under licensed 503A pharmacy standards, we’re authorized to compound THC-free CBD isolate as an active pharmaceutical ingredient (API).
These therapies aren’t shelf-ready products—they’re patient-specific solutions made to exacting pharmacy standards, rigorously tested, and delivered through a HIPAA-secure, eRx-to-door workflow. By replacing retail guesswork with medical oversight, condition-specific protocols, and provider partnership, Kazmira restores clinical trust in cannabinoid care—real medicine without the stigma or recreational noise.
Prescription relief for real conditions without the hype.
What Makes Kazmira Different?
Why Providers Trust Kazmira
Clinically Compounded
Kazmira operates under licensed 503A pharmacy standards to compound CBD as a prescription therapy—not a shelf product.
Physician-Guided
Every formulation is prescribed by licensed providers with condition-specific protocols for anxiety, pain, PTSD, and recovery.
Pharmacy-Credible
We meet or exceed GMP, ISO, and USP 795 standards, with pharmacist oversight and third-party testing on every batch.
Patient-Centered
HIPAA-secure workflows, eRx convenience, refill support, and a stigma-free experience designed for real people—not retail.
Beyond clean — clinically credible.
Beyond clean. clinically credible.
Clinical Standards: We don’t sell shelf products. We deliver clinical solutions — with protocols, QA systems, and documentation that meet or exceed the standards set by the U.S. Pharmacopeia (USP), ISO, and GMP.
We Comply With:
503A state pharmacy license
USP <795> non-sterile compounding guidelines
ISO 17025 & 9001 testing standards
GMP-aligned production workflows
Surescripts-certified eRx systems
Each formulation is produced under pharmacist supervision, batch-tested for potency and purity, and verified for THC-free integrity. Our facility uses ISO-17025 certified lab methods, HIPAA-secure data handling, and GMP-aligned production controls to ensure clinical-grade consistency at every step. Every order includes full chain-of-custody tracking, pharmacist oversight, and patient-specific documentation — delivering peace of mind for both providers and patients.
Safety & Compliance
At Kazmira, every therapy follows a closed-loop, pharmacist-verified workflow designed to minimize risk and maximize trust. From the moment a prescription is submitted to the moment a therapy is delivered, we maintain full visibility, control, and documentation across every step:
Secure, compliant, and built for clinical trust:
HIPAA-secure intake and eRx submission
Patient-specific compounding by licensed pharmacists
Lot-level traceability and audit-ready documentation
Drug-test safe, THC-free assurance on every order
Refill tracking and oversight for continuity of care
We don’t just meet compliance standards — we operationalize them. Our systems are designed to reduce provider liability, eliminate patient confusion, and deliver transparent, traceable care from start to ship.
Conditions We Support
Anxiety and Pain Don’t Exist in Silos — So We Don’t Address Them in Isolation. Anxiety and chronic pain frequently reinforce each other — neurologically, emotionally, and clinically. Our therapies are clinically dosed and supported by physician protocols for common and comorbid conditions such as:
Generalized Anxiety
Disorder (GAD)
PTSD & nervous system
dysregulation
Chronic
musculoskeletal pain
Fibromyalgia, IBS, and
neuropathic pain
Kazmira compounds high-purity, THC-free CBD as a therapeutic tool to help providers break this loop — without resorting to polypharmacy or guesswork. We’re not replacing first-line meds; we’re giving clinicians a pharmacist-compounded option when conventional approaches fall short.
One prescription. Two conditions. Real relief.
Ready to Take The Next Step?
Whether you’re a provider or a patient, we’re here to answer questions, walk you through the process, and help you get started.